Driving Simulation to Assess Non-Sedative Effects of Tolperisone
Clinical trial NCT03353922 · COMPLETED
Trial details
- NCT number
- NCT03353922
- Sponsor
- Neurana Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2017-12-06
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.